NeurAxis, Inc. (NRXS), a medical technology company, on Wednesday announced it has entered into definitive agreements to sell about 1.5 million shares at $3.25 per share.
Shares of NeurAxis are decreasing by around 24% in the pre-market trading.
The 1,538,461 offering is expected to close on or about May 22
NeurAxis expects to raise approximately $5 million in gross proceeds from the offering. The company said it plans to use the net proceeds for working capital and general corporate purposes.
In the pre-market trading, NeurAxis is 24.06% lesser at $3.0300 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.